TrialBritish journal of cancer2012

Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α.

S Patil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.